Research progress on the role of transmembrane proteins in malignant tumors

doi:10.16352/j.issn.1001-6325.2024.03.0398

Abstract

Abstract: Transmembrane proteins (TMEMs) are a class of family proteins that span lipid bilayers, serving as crucial channel proteins on biological membranes, playing essential physiological roles. TMEMs′ over-expression in malignant tumors, such as TMEM16A and TMEM206, has been linked to the promotion of malignancy. Conversely, down-regulation of TMEM100 expression has been associated with tumor progression. TMEM98, whose expression varies across different malignancies.TMEMs has shown promise as both a therapeutic target and a prognostic marker in cancer.Additionally, TMEMs play a vital role in various malignancies by modulating the Wnt and AKT signaling pathways through interaction with different upstream and downstream regulatory factors. Furthermore, research has provided additional insights into their role in cisplatin-related chemoresistance in specific malignant tumor cell populations.

Key words: transmembrane protein, cancer, signaling pathway, chemoresistance

CLC Number:

WANG Zihao, XIA Xiaochao, LI Shun. Research progress on the role of transmembrane proteins in malignant tumors[J]. Basic & Clinical Medicine, 2024, 44(3): 398-402.

References 27

[1]	Bae Y, Lee SK, Chae YC, et al. Accessibility-dependent topology studies of membrane proteins using a SpyTag/SpyCatcher protein-ligation system[J]. Int J Biol Macromol, 2021, 175: 171-178.
[2]	Zhang N, Pan H, Liang X, et al. The roles of transmembrane family proteins in the regulation of store-operated Ca2+ entry[J]. Cell Mol Life Sci, 2022, 79: 118.doi:10.1007/s00018-021-04034-y.
[3]	Li C, Ou R, Chen Y, et al. Mutation analysis of TMEM family members for early-onset Parkinson′s disease in Chinese population[J]. Neurobiol Aging, 2021, 101: 299.e1-299.e6.doi:10.1016/j.neurobiolaging.2020.11.005.
[4]	Ji W, Shi D, Shi S, et al. TMEM16A protein: calcium-binding site and its activation mechanism[J]. PPL, 2021, 28: 1338-1348.
[5]	Ma K, Liu S, Liang H, et al. Ca2+-activated Cl-channel TMEM16A inhibition by cholesterol promotes angiogenesis in endothelial cells[J]. J Adv Res, 2021, 29: 23-32.
[6]	Luo S, Wang H, Bai L, et al. Activation of TMEM16A Ca2+-activated Cl-channels by ROCK1/moesin promotes breast cancer metastasis[J]. J Adv Res, 2021, 33: 253-264.
[7]	Yang J, Chen J, Del Carmen Vitery M, et al. PAC, an evolutionarily conserved membrane protein, is a proton-activated chloride channel[J]. Science, 2019, 364: 395-399.
[8]	Zha X, Xiong Z, Simon R, et al. pH and proton-sensitive receptors in brain ischemia[J]. J Cereb Blood Flow Metab, 2022,42:1349-1363.
[9]	Mihaljević L, Ruan Z, Osei-Owusu J, et al. Inhibition of the proton-activated chloride channel PAC by PIP2[J]. eLife, 2023, 12: e83935. doi: 10.7554/eLife.83935.
[10]	Peng F, Li H, Li J, et al.Downregulation of the proton-activated Cl- channel TMEM206 inhibits malignant properties of human osteosarcoma cells[J]. Oxid Med Cell Longev, 2021, 2021: 1-16.
[11]	Li M, Zhu H, Hu X, et al. TMEM98, a novel secretory protein, promotes endothelial cell adhesion as well as vascular smooth muscle cell proliferation and migration[J]. Can J Physiol Pharmacol, 2021, 99: 536-548.
[12]	Li J, Chen W, Luo L, et al. The microRNA miR-29c-5p inhibits cell proliferation and migration by targeting TMEM98 in head and neck carcinoma[J]. Aging, 2021, 13: 769-781.
[13]	Ao X, Li X, Chen Y, et al. TMEM98 mRNA promotes proliferation and invasion of gastric cells by directly interacting with NF90 protein[J]. Cell Biol Int, 2020, 44: 1820-1830.
[14]	Wu SG, Xu JY, Lei J, et al. Tumor-suppressor gene transmembrane protein 98 promotes proliferation and inhibits apoptosis in ovarian cancer[J]. Front Biosci(Landmark Ed), 2022, 27: 210. doi: 10.31083/j.fbl2707210.
[15]	He Q, Dong Y, Zhu Y, et al. TMEM100 induces cell death in non-small cell lung cancer via the activation of autophagy and apoptosis[J]. Oncol Rep, 2021, 45: 63. doi: 10.3892/or.2021.8014.
[16]	Li H, Cheng C, You W, et al. TMEM100 modulates TGF-β signaling pathway to inhibit colorectal cancer progression[J]. Gastroent Res Pract, 2021, 2021: 1-10.
[17]	Ye Z, Xia Y, Li L, et al. Effect of transmembrane protein 100 on prostate cancer progression by regulating SCNN1D through the FAK/PI3K/AKT pathway[J]. Transl Oncol, 2023, 27: 101578. doi: 10.1016/j.tranon.2022.101578.
[18]	Liu J, Xiao Q, Xiao J, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities[J]. Sig Transduct Target Ther, 2022, 7: 3. doi: 10.1038/s41392-021-00762-6.
[19]	Xu J, Su Z, Ding Q, et al. Inhibition of proliferation by knockdown of transmembrane (TMEM) 168 in glioblas-toma cells via suppression of Wnt/β-Catenin pathway[J]. oncol res, 2019, 27: 819-826.
[20]	Jiang XY, Wang L, Liu ZY, et al. TMEM48 promotes cell proliferation and invasion in cervical cancer via activation of the Wnt/β-catenin pathway[J]. J Recept Sig Transd, 2021, 41: 371-377.
[21]	Zhao X, Li G, Chong T, et al. TMEM88 exhibits an antiproliferative and anti-invasive effect in bladder cancer by downregulating Wnt/β-catenin signaling[J]. J Biochem Molecular Tox, 2021, 35: e22835. doi: 10.1002/jbt.22835.
[22]	Chen J, Wang D, Chen H, et al. TMEM196 inhibits lung cancer metastasis by regulating the Wnt/β-catenin signaling pathway[J]. J Cancer Res Clin Oncol, 2023, 149: 653-667.
[23]	Revathidevi S, Munirajan AK. Akt in cancer: mediator and more[J]. Semin Cancer Biol, 2019, 59: 80-91.
[24]	Zhan B, Zhang Z, Piao C, et al. The sigma-2 receptor/TMEM97 agonist PB28 suppresses cell proliferation and invasion by regulating the PI3K-AKT-mTOR signalling pathway in renal cancer[J]. J Cellular Molecular Medi, 2021, 25: 11244-11256.
[25]	Zhang X, He Y, Jiang Y, et al. TMEM229A suppresses non-small cell lung cancer progression via inactivating the ERK pathway[J]. Oncol Rep, 2021, 46: 176. doi: 10.3892/or.2021.8127.
[26]	Tchounwou PB, Dasari S, Noubissi FK, et al. Advances in our understanding of the molecular mechanisms of action of cisplatin in cancer therapy[J]. JEP, 2021, 13: 303-328.
[27]	Shen D, Ma J, Okabe M, et al. Elevated expression of TMEM205, a hypothetical membrane protein, is associa-ted with cisplatin resistance[J]. J Cell Physiol, 2010, 225: 822-828.